Form Id: FRM_RCA_VAC_ENF
ENGLISH FRANÇAIS PORTUGUÊS ITALIANO| BCG - 1 dose: | |
| Hep B - 1 dose: | |
- | |
| VPOb - 0 dose - A la naissance: | |
| VPOb - 1ère dose - A 6 semaines: | |
| VPOb - 2ème dose - A 10 semaines: | |
| VPOb - 3ème dose - A 14 semaines: | |
- | |
| VPI - 1 dose A 14 semaines: | |
- | |
| DTC-HepB-HIb 1ère dose a 6 semaines: | |
| DTC-HepB-HIb 2ème dose a 10 semaines: | |
| DTC-HepB-HIb 3ème dose a 14 semaines: | |
- | |
| PCV13 - 1ère dose A 6 semaines: | |
| PCV13 - 2ème dose A 10 semaines: | |
| PCV13 - 3ème dose A 14 semaines: | |
- | |
| ROTA_Liq - 1ère dose - A 6 semaines: | |
| ROTA_Liq - 2ème dose - A 10 semaines: | |
| ROTA_Liq - 3ème dose: | |
- | |
| VAR/RR 1 dose A neuf (9) mois: | |
| VAA 1 dose A neuf (9) mois: | |
| MenAfriVac - 1 dose A neuf (9) mois: | |
| VITAMIE A 100.000 UI - 1 dose De 6 a 11 mois: | |
| VITAMIE A 200.000 UI - De 12 a 59 mois: | |
| MR - Rougeole-Rubéole 1 dose: | |
| MR - Rougeole-Rubéole 2ème dose: | |
Adverse Events | |
| Squint/White Eye reflection under 1 year: | |
| Adverse Events Following immunization (AEFI): | |
Note: Any gray lines, in production, will be enabled under pre-set conditions, but this functionality does not work in this preview
